Sustained Clinical Response in Psoriatic Arthritis Patients Treated with Anti-TNF Agents: A 5-year Open-Label Observational Cohort Study von Saougou, Ioanna, MD, Markatseli, Theodora E., MD, Papagoras, Charalampos, MD, Voulgari, Paraskevi V., MD, Alamanos, Yannis, MD, Drosos, Alexandros A., MD, FACR

Volltext

Survival of TNF-alpha antagonists in rheumatoid arthritis: a long-term study von MARKATSELI, T. E, ALAMANOS, Y, SAOUGOU, I, VOULGARI, P. V, DROSOS, A. A

Volltext

Fertility in male patients with seronegative spondyloarthropathies treated with infliximab von Saougou, Ioanna, Markatseli, Theodora E, Papagoras, Charalampos, Kaltsonoudis, Evripidis, Voulgari, Paraskevi V, Drosos, Alexandros A

Volltext

Maintained clinical response of infliximab treatment in ankylosing spondylitis: A 6-year long-term study von Saougou, Ioanna, Markatseli, Theodora E, Voulgari, Paraskevi V, Drosos, Alexandros A

Volltext

case report of a psoriatic arthritis patient on hemodialysis treated with tumor necrosis factor blocking agent and a literature review von Saougou, Ioanna, Papagoras, Charalampos, Markatseli, Theodora E, Voulgari, Paraskevi V, Drosos, Alexandros A

Volltext

Risque cardiovasculaire type chez les patients atteints de spondylarthrite ankylosante von Papagoras, Charalampos, Markatseli, Theodora E., Saougou, Ioanna, Alamanos, Yannis, Zikou, Anastasia K., Voulgari, Paraskevi V., Kiortsis, Dimitrios N., Drosos, Alexandros A.

Volltext

Fertilité des hommes atteints d’une spondylarthropathie et traités par infliximab von Saougou, Ioanna, Markatseli, Theodora E., Papagoras, Charalampos, Kaltsonoudis, Evripidis, Voulgari, Paraskevi V., Drosos, Alexandros A.

Volltext

Maintien de la réponse clinique au traitement par infliximab au cours de la spondylarthrite ankylosante : suivi à six ans von Saougou, Ioanna, Markatseli, Theodora E., Voulgari, Paraskevi V., Drosos, Alexandros A.

Volltext